141 related articles for article (PubMed ID: 34534610)
21. Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro.
Miropolskaya N; Kozlov M; Petushkov I; Prostova M; Pupov D; Esyunina D; Kochetkov S; Kulbachinskiy A
Biochimie; 2023 Mar; 206():81-88. PubMed ID: 36252889
[TBL] [Abstract][Full Text] [Related]
22. Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination.
Padhi AK; Dandapat J; Saudagar P; Uversky VN; Tripathi T
FEBS Lett; 2021 Sep; 595(18):2366-2382. PubMed ID: 34409597
[TBL] [Abstract][Full Text] [Related]
23. State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2.
Tanimoto S; Itoh SG; Okumura H
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142270
[TBL] [Abstract][Full Text] [Related]
24. Targeting Viral RNA-Dependent RNA Polymerases as an Antiviral Therapy.
Miranda D; Sanchez DJ
Curr Med Chem; 2021; 28(40):8384-8391. PubMed ID: 33563150
[TBL] [Abstract][Full Text] [Related]
25. Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp).
Karthic A; Kesarwani V; Singh RK; Yadav PK; Chaturvedi N; Chauhan P; Yadav BS; Kushwaha SK
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164069
[TBL] [Abstract][Full Text] [Related]
26. Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2.
Shehzadi K; Saba A; Yu M; Liang J
Top Curr Chem (Cham); 2023 Jun; 381(5):22. PubMed ID: 37318607
[TBL] [Abstract][Full Text] [Related]
27. Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp).
Bibi S; Hasan MM; Wang YB; Papadakos SP; Yu H
Curr Med Chem; 2022; 29(1):152-162. PubMed ID: 34420502
[TBL] [Abstract][Full Text] [Related]
28. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2.
Mishra A; Rathore AS
Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060
[TBL] [Abstract][Full Text] [Related]
29. Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
Tsuji M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232311
[TBL] [Abstract][Full Text] [Related]
30. Structural insight into the binding interactions of NTPs and nucleotide analogues to RNA dependent RNA polymerase of SARS-CoV-2.
Koulgi S; Jani V; V N MU; Sonavane U; Joshi R
J Biomol Struct Dyn; 2022 Oct; 40(16):7230-7244. PubMed ID: 33682633
[TBL] [Abstract][Full Text] [Related]
31. RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target.
Wang Y; Anirudhan V; Du R; Cui Q; Rong L
J Med Virol; 2021 Jan; 93(1):300-310. PubMed ID: 32633831
[TBL] [Abstract][Full Text] [Related]
32. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
Chowdhury T; Roymahapatra G; Mandal SM
Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300
[TBL] [Abstract][Full Text] [Related]
33. Favipiravir in SARS-CoV-2 Infection: Is it Worth it?
Batiha GE; Moubarak M; Shaheen HM; Zakariya AM; Usman IM; Rauf A; Adhikari A; Dey A; Alexiou A; Hetta HF; Al-Gareeb AI; Al-Kuraishy HM
Comb Chem High Throughput Screen; 2022; 25(14):2413-2428. PubMed ID: 35430987
[TBL] [Abstract][Full Text] [Related]
34. "Bucket brigade" using lysine residues in RNA-dependent RNA polymerase of SARS-CoV-2.
Tanimoto S; Itoh SG; Okumura H
Biophys J; 2021 Sep; 120(17):3615-3627. PubMed ID: 34339634
[TBL] [Abstract][Full Text] [Related]
35. Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2.
Dey SK; Saini M; Dhembla C; Bhatt S; Rajesh AS; Anand V; Das HK; Kundu S
J Biomol Struct Dyn; 2022; 40(24):14067-14083. PubMed ID: 34784490
[TBL] [Abstract][Full Text] [Related]
36. Biostructural Models for the Binding of Nucleoside Analogs to SARS-CoV-2 RNA-Dependent RNA Polymerase.
Prussia AJ; Chennamadhavuni S
J Chem Inf Model; 2021 Mar; 61(3):1402-1411. PubMed ID: 33655751
[TBL] [Abstract][Full Text] [Related]
37. Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
Dhankhar P; Dalal V; Kumar V
J Comput Biol; 2021 Dec; 28(12):1228-1247. PubMed ID: 34847746
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target.
Yashvardhini N; Jha DK; Bhattacharya S
Arch Microbiol; 2021 Nov; 203(9):5463-5473. PubMed ID: 34410443
[TBL] [Abstract][Full Text] [Related]
39. A computational comparative analysis of the binding mechanism of molnupiravir's active metabolite to RNA-dependent RNA polymerase of wild-type and Delta subvariant AY.4 of SARS-CoV-2.
Celik I; Tallei TE
J Cell Biochem; 2022 Apr; 123(4):807-818. PubMed ID: 35132671
[TBL] [Abstract][Full Text] [Related]
40. 5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis.
Zhao J; Liu Q; Yi D; Li Q; Guo S; Ma L; Zhang Y; Dong D; Guo F; Liu Z; Wei T; Li X; Cen S
Antiviral Res; 2022 Feb; 198():105254. PubMed ID: 35101534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
